Moreover, aggregates of alpha-synuclein are observed in the skin and are similar to those observed in the brain [6], and the seeding capacity of PD-patient-skin-derived alpha-synuclein may be used for the antemortem diagnosis of PD and other synucleinopathies [7]. Here, SNCA is linked to Parkinson disease.